ROKIT Healthcare Inc. (376900.KQ) has a MoatMap StockRank of 22/100 based on Quality (40/100), Value (35/100), and Momentum (33/100) factor scores. The current signal is SELL.
ROKIT Healthcare Inc., a biotechnology company, provides hyper-personalized organ regenerative healthcare solutions in South Korea.
| Price | $33.24 |
| Market Cap | $504M |
| Price/Book | 67.35 |
| Return on Equity | -24.6% |
| Return on Invested Capital | 18.4% |
| Debt/Equity | 75.77 |
| Gross Margin | 59.3% |
| Operating Margin | -27.3% |
| Revenue Growth | 118.1% |
| Free Cash Flow | $-2K |
ROKIT Healthcare Inc. operates in the Medical Care Facilities industry, part of the Healthcare sector (South Korea).